Pharmaceuticals News and Research

RSS

Congress likely to approve FDA prescription drug safety reforms in 2007

The Baltimore Sun on Friday examined how Democrats' takeover of Congress and the expiration of a law that requires drug manufacturers to pay user fees to FDA "is driving a flurry of activity that could lead to major changes" in the agency's drug safety policies.

12 Feb 2007

PALB2 gene mutation elevates risk of breast cancer four-fold

Cancer is a complex and common disease caused by a combination of both genetic and environmental factors. An inherited predisposition seems to be involved in at least 5-10 per cent of all cases of breast cancer.

11 Feb 2007

Researchers discover master switch for a tumor suppressive network

A decades-old cancer mystery has been solved by researchers at Cold Spring Harbor Laboratory (CSHL). "We not only found a critical tumor suppressor gene, but have revealed a master switch for a tumor suppressive network that means more targeted and effective cancer therapy in the future," said CSHL Associate Professor Alea Mills, Ph.D.

11 Feb 2007

New microscopy technology

Research is finding evidence that may solve one of the great puzzles of 21st Century medicine using a new microscopy technology known as CytoViva.

11 Feb 2007

QLT USA settles U.S. patent litigation

QLT Inc. announced that its wholly-owned subsidiary, QLT USA, Inc. (formerly Atrix Laboratories, Inc.) has reached an agreement to settle the litigation captioned "TAP Pharmaceutical Products Inc., Takeda Chemical Industries, Ltd. and Wako Pure Chemical Industries, Ltd. v. Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc.," # 03-C-7822, United States District Court for the Northern District of Illinois and the appeal pending therefrom in the United States Court of Appeals for the Federal Circuit.

11 Feb 2007

End of an era for DNA patenting

Human DNA patents are unlikely to be the barrier to medical and scientific innovation that they were first feared to be, according to new findings published this week.

8 Feb 2007

AIDS activists call for gel trials to restart

AIDS activists in South Africa are calling for clinical trials of a microbicide gel designed to help women protect themselves against HIV to be restarted.

8 Feb 2007

WHO cautions Thailand against issuing compulsory license for antiretroviral Kaletra

The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports.

7 Feb 2007

Most of Medicare and Medicaid savings in Bush's budget proposal come from reducing growth in Medicare provider payments

The "lion's share" of the Medicare and Medicaid savings over five years proposed in President Bush's fiscal year 2008 budget proposal comes from limits on annual inflation adjustments for reimbursements to hospitals, nursing homes and other health care providers for Medicare, amounting to $39.5 billion, CQ HealthBeat reports.

7 Feb 2007

Ban called for on newer birth control pills

The advocacy group Public Citizen has filed a petition with the Food and Drug Administration (FDA) demanding that the sale of some of the newer birth control pills be banned.

6 Feb 2007

Britain to debate availability of HRT and the pill over the counter

The organisation in the UK which regulates drugs and treatments, the Medicines and Healthcare Products Regulatory Agency (MHRA) is to hold a seminar in London as part of a campaign to improve women's health.

6 Feb 2007

Many low-income Medicare beneficiaries receive no help from PAPs

Many low-income Medicare beneficiaries enrolled in the prescription drug benefit receive no help from patient assistance programs operated by pharmaceutical companies, according to advocacy groups, USA Today reports.

6 Feb 2007

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

GlaxoSmithKline has issued an update on US patent litigation regarding Valtrex (valacyclovir), an antiviral drug used for the treatment and suppression of genital herpes, herpes zoster (shingles), and cold sores.

5 Feb 2007

Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus

The layers of mucus that protect sensitive tissue throughout the body have an undesirable side effect: they can also keep helpful medications away.

5 Feb 2007

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharmaceuticals has announced it has initiated a Phase 2 clinical trial of its lead compound MitoQ (mitoquinone) to investigate the drug's efficacy to reduce liver damage in patients with raised liver enzymes associated with the Hepatitis C virus (HCV).

5 Feb 2007

Direct synthesis of polymer nanocapsules with a noncovalently tailorable surface

To accurately transport pharmaceutical agents to their specific target organs or cell types, you need a good carrier: nanoscopic capsules with surface elements that can "recognize" the target in question could do the trick.

5 Feb 2007

Disappointing end to trials of new gel to protect women against AIDS

In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.

1 Feb 2007

FDA approves Neuren's phase 3 Glypromate trial

Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.

30 Jan 2007

Novartis' day in court could leave millions without AIDS drugs

The Swiss pharmaceutical giant Novartis is in court in India this week challenging the country's patent laws.

30 Jan 2007

Access Pharmaceuticals issued U.S. patent

This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.

30 Jan 2007